Person profile

Public information reviewed
Portrait of Derica W. Rice

Derica W. Rice

Board role

Director · Bristol Myers Squibb (NYSE: CELG-RI)

Board role

Director · Target Corporation (NYSE: TGT)

Board role

Director · Carlyle Group Inc. (NASDAQ: CGABL)

Board role

Director · Walt Disney (NYSE: DIS)

Bristol Myers Squibb (NYSE: CELG-RI)

Director · Current mandate

Director · Board · Executive
FollowSave PDF
More
Reports & analysisAlpha Eval
Public sources
16 reviewed
Profile ownership
Not yet claimed
Last reviewed
Sep 2, 2026
View sources

Profile

Identity, professional record and current appointments.

Overview

Professional record at a glance

A concise summary of information supported by the cited public sources. Missing information is treated as unknown, not as a negative finding.

Current roles
44 current organizations shown on this profile
Board positions
44 supported by public sources, 0 supplied by the profile owner
Committee roles
6Roles supported by the sources cited on this profile
Qualifications
Not establishedNo qualification is currently confirmed by the cited sources

Professional narrative

About

Derica Rice is the former Executive Vice President of CVS Health and President of Pharmacy Benefits Management Business. He previously served as Chief Financial Officer and Executive Vice President of Global Services at Eli Lilly and Company, bringing extensive healthcare and financial expertise.

Sources are shown with the information they support.

Current roles

Appointments & responsibilities

Board appointments

Director

Walt Disney (NYSE: DIS)

Jan 1, 2019 – Present

Independence: Not stated

Source effective: 2019-01-01 · Observed: 2026-05-03T01:47:43.848553+00:00

confirmedView source

Governance

Board appointments, committee responsibilities and disclosed relationships.

Board and advisory record

Board service

Sources are shown with each role, education record, or credential.

Director

Bristol Myers Squibb

2026-03-25 · current

Confirmed by public sourceView source

Director

Target Corporation

2025-04-28 · current

Confirmed by public sourceView source

Director

Carlyle Group Inc.

2021-01-01 · current

Confirmed by public sourceView source

Director

Walt Disney

2019-01-01 · current

Confirmed by public sourceView source

Connections

Explore the roles, education and affiliations published in this record.

Bristol Myers Squibb

Open Bristol Myers Squibb profile →

Director at Bristol Myers Squibb

2026-03-25 → End not stated

current · source reported

Observed: 2026-09-21

Bristol Myers SquibbBristol Myers SquibbCarlyle Group Inc.Carlyle Group Inc.Target CorporationTarget CorporationWalt DisneyWalt DisneyDerica W. Rice

Dashed lines mark past roles. Select a connection to see its dates and sources.

Relationship map

Connected through the public record

Direct relationships from verified facts and published résumé records. Private connections are excluded.

Direct public links only

Only published affiliations are shown here. Private relationships require authorized access.

Experience

Career history, education, credentials and public contributions.

Published record

Featured coverage

Selected publications and public sources used to establish this profile. Inclusion records provenance; it is not an endorsement.

Source 1 · Sec FilingMDXG DEF 14A executive officersSupports Executive company, Executive title.Open sourceSource 2 · Sec FilingCarlyle Group Inc director board sourceSupports Board membership, Committee assignments, Director since, Board independence.Open sourceSource 3 · Sec FilingAPTOF 10-K executive officersSupports AI and ML experience, Cybersecurity experience, Executive company, Executive title, Technology background.Open sourceSource 4 · Sec FilingBMY DEF 14A director slateSupports AI and ML experience, Board role, Committee assignments, Cybersecurity experience, Technology background.Open sourceSource 5 · Sec FilingWalt Disney director board sourceSupports Board membership, Committee assignments, Director since, Board independence.Open sourceSource 6 · Sec FilingTGT DEF 14A director slateSupports Board role, Committee assignments.Open source

Basis

Identifiers, sources, dates and record limitations.

Identifiers

Alpha ID
alpha:person:derica-w-rice
Record version
public-0

Sources

Sources and published information

Each item links to the public source used to support it. When sources disagree, the item is clearly marked for review.

AI and ML experience · CorroboratedAI and ML experience: not identified in the cited filingSupported by 2 public records2 sources
Verification
Corroborated
Confidence
72%
Last reviewed
May 16, 2026
  • SEC EDGAR

    Sec Filing · Tier 3 · Reviewed May 15, 2026

  • SEC EDGAR

    Sec Filing · Tier 3 · Reviewed May 16, 2026

Board independence · CorroboratedIndependent directorSupported by 2 public records2 sources
Verification
Corroborated
Confidence
95%
Last reviewed
May 3, 2026
  • SEC EDGAR

    Sec Filing · Tier 3 · Reviewed May 3, 2026

  • SEC EDGAR

    Sec Filing · Tier 3 · Reviewed May 3, 2026

Board membership · CorroboratedServes on the board of Bristol Myers SquibbSupported by 3 public records3 sources
Verification
Corroborated
Confidence
95%
Last reviewed
May 3, 2026
Board membership · CorroboratedServes on the board of Carlyle Group IncSupported by 4 public records3 sources
Verification
Corroborated
Confidence
95%
Last reviewed
May 3, 2026
Board membership · CorroboratedServes on the board of Target CorporationSupported by 3 public records3 sources
Verification
Corroborated
Confidence
95%
Last reviewed
May 3, 2026
Board membership · CorroboratedServes on the board of Walt DisneySupported by 4 public records3 sources
Verification
Corroborated
Confidence
95%
Last reviewed
May 3, 2026
Board role · CorroboratedBoard role: DirectorSupported by 4 public records4 sources
Verification
Corroborated
Confidence
92%
Last reviewed
May 16, 2026
  • SEC EDGAR

    Sec Filing · Tier 3 · Reviewed May 7, 2026

  • SEC EDGAR

    Sec Filing · Tier 3 · Reviewed May 16, 2026

  • SEC EDGAR

    Sec Filing · Tier 3 · Reviewed May 15, 2026

  • SEC EDGAR

    Sec Filing · Tier 3 · Reviewed May 15, 2026

Committee assignments · CorroboratedNo committee assignment disclosed in the cited filingSupported by 2 public records2 sources
Verification
Corroborated
Confidence
95%
Last reviewed
May 3, 2026
  • SEC EDGAR

    Sec Filing · Tier 3 · Reviewed May 3, 2026

  • SEC EDGAR

    Sec Filing · Tier 3 · Reviewed May 3, 2026

Committee assignments · Source reportedCommittee assignments: Audit1 source
Verification
Source reported
Confidence
88%
Last reviewed
May 15, 2026
  • SEC EDGAR

    Sec Filing · Tier 3 · Reviewed May 15, 2026

Committee assignments · Source reportedCommittee assignments: Audit Committee, Compensation and Management Development Committee1 source
Verification
Source reported
Confidence
88%
Last reviewed
May 16, 2026
  • SEC EDGAR

    Sec Filing · Tier 3 · Reviewed May 16, 2026

Committee assignments · Source reportedCommittee assignments: Audit & Risk, Infrastructure & Finance1 source
Verification
Source reported
Confidence
88%
Last reviewed
May 15, 2026
  • SEC EDGAR

    Sec Filing · Tier 3 · Reviewed May 15, 2026

Committee assignments · Source reportedCommittee assignments: Audit, Compensation1 source
Verification
Source reported
Confidence
88%
Last reviewed
May 7, 2026
  • SEC EDGAR

    Sec Filing · Tier 3 · Reviewed May 7, 2026

Cybersecurity experience · CorroboratedCybersecurity experience: not identified in the cited filingSupported by 2 public records2 sources
Verification
Corroborated
Confidence
72%
Last reviewed
May 16, 2026
  • SEC EDGAR

    Sec Filing · Tier 3 · Reviewed May 16, 2026

  • SEC EDGAR

    Sec Filing · Tier 3 · Reviewed May 15, 2026

Executive company · Source reportedExecutive at Aptose Biosciences Inc.1 source
Verification
Source reported
Confidence
94%
Last reviewed
May 15, 2026
  • SEC EDGAR

    Sec Filing · Tier 3 · Reviewed May 15, 2026

Executive company · Source reportedExecutive at MIMEDX GROUP, INC.1 source
Verification
Source reported
Confidence
94%
Last reviewed
May 4, 2026
  • SEC EDGAR

    Sec Filing · Tier 3 · Reviewed May 4, 2026

Executive title · Source reportedExecutive title: Chairman of the Board and Chief Executive Officer1 source
Verification
Source reported
Confidence
94%
Last reviewed
May 15, 2026
  • SEC EDGAR

    Sec Filing · Tier 3 · Reviewed May 15, 2026

Executive title · Source reportedExecutive title: Named Executive Officer / Executive Officer1 source
Verification
Source reported
Confidence
94%
Last reviewed
May 4, 2026
  • SEC EDGAR

    Sec Filing · Tier 3 · Reviewed May 4, 2026

Technology background · CorroboratedTechnology background: not identified in the cited filingSupported by 2 public records2 sources
Verification
Corroborated
Confidence
72%
Last reviewed
May 16, 2026
  • SEC EDGAR

    Sec Filing · Tier 3 · Reviewed May 15, 2026

  • SEC EDGAR

    Sec Filing · Tier 3 · Reviewed May 16, 2026

View all sources16 records
  1. SEC EDGAR

    Sec Filing · Tier 3 · Reviewed May 4, 2026

    Supports: Executive company · Executive title

  2. SEC EDGAR

    Sec Filing · Tier 3 · Reviewed May 3, 2026

    Supports: Board membership · Committee assignments · Director since · Board independence

  3. SEC EDGAR

    Sec Filing · Tier 3 · Reviewed May 7, 2026

    Supports: Board role · Committee assignments

  4. SEC EDGAR

    Sec Filing · Tier 3 · Reviewed May 15, 2026

    Supports: AI and ML experience · Cybersecurity experience · Executive company · Executive title · Technology background

  5. SEC EDGAR

    Sec Filing · Tier 3 · Reviewed May 16, 2026

    Supports: AI and ML experience · Board role · Committee assignments · Cybersecurity experience · Technology background

  6. https://www.sec.gov/Archives/edgar/data/14272/000001427226000006/bmy-20260325.htm

    Sec Filing · Tier not stated · Reviewed May 16, 2026

    Supports: Director at Bristol Myers Squibb (NYSE: CELG-RI)

  7. SEC EDGAR

    Sec Filing · Tier 3 · Reviewed May 3, 2026

    Supports: Board membership · Committee assignments · Director since · Board independence

  8. SEC EDGAR

    Sec Filing · Tier 3 · Reviewed May 15, 2026

    Supports: Board role · Committee assignments

  9. SEC EDGAR

    Sec Filing · Tier 3 · Reviewed May 15, 2026

    Supports: Board role · Committee assignments

  10. https://www.sec.gov/Archives/edgar/data/0000027419/000162828025020275/tgt-20250428.htm

    Sec Filing · Tier not stated · Reviewed May 15, 2026

    Supports: Director at Target Corporation (NYSE: TGT)

  11. https://www.sec.gov/Archives/edgar/data/1527166/000152716626000017/cg-20260423.htm

    Sec Filing · Tier not stated · Reviewed May 3, 2026

    Supports: Director at Carlyle Group Inc. (NASDAQ: CGABL)

  12. https://www.sec.gov/Archives/edgar/data/0001744489/000174448926000013/dis-20260122.htm

    Sec Filing · Tier not stated · Reviewed May 3, 2026

    Supports: Director at Walt Disney (NYSE: DIS)

  13. https://www.sec.gov/Archives/edgar/data/14272/000001427226000006/bmy-20260325.htm

    Public Source · Tier not stated · Reviewed Not stated

    Supports: Board membership

  14. https://www.sec.gov/Archives/edgar/data/0000027419/000162828025020275/tgt-20250428.htm

    Public Source · Tier not stated · Reviewed Not stated

    Supports: Board membership

  15. https://www.sec.gov/Archives/edgar/data/1527166/000152716626000017/cg-20260423.htm

    Public Source · Tier not stated · Reviewed Not stated

    Supports: Board membership

  16. https://www.sec.gov/Archives/edgar/data/0001744489/000174448926000013/dis-20260122.htm

    Public Source · Tier not stated · Reviewed Not stated

    Supports: Board membership